WHO ICTRP trial
The effects of probiotic and prebiotic in Nonalcoholic fatty liver disease.
IRCT201301223140N6 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201301223140N6 |
|---|---|
| Public title | The effects of probiotic and prebiotic in Nonalcoholic fatty liver disease. |
| Scientific title | The effects of probiotic, prebiotic and concomitant supplementation of probiotic, Prebiotic on the oxidative stress, inflammatory and insulin resistance indices, lipid profile and liver function in non-alcoholic fatty liver. patients. |
| Primary sponsor | Vice-chancellor for research-Tabriz University of Medical Science |
| Secondary sponsors | Nutrition Research Center of Univercity Medicinal Science Tabriz |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Non alcoholic fatty liver. Other diseases of liver;Other diseases of liver |
| Interventions | Intervention 1: Intervention groups: Group1 treated with 1 gr of probiotic capcul (107 Bifidobacterium longum and Lactobacillus acidophilus) and 5 gr of prebiotic plasebo (multodextrose) twice a day for 3 months. Group 2 treated with 5 gr… |
| Registration date | Jan 16, 2014 |
| Target size | 88 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: